Nephros (NEPH) Revenue (2010 - 2026)

Nephros' Revenue history runs 17 years deep, the most recent figure standing at $5.2 million for Q1 2026.

• On a quarterly basis, Revenue rose 6.87% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $19.1 million, a 23.25% increase from a year earlier, with the FY2025 full-year figure at $18.8 million, up 32.67% from the prior year.
• Revenue grew to $5.2 million in Q1 2026 per NEPH's latest filing, from $4.7 million in the prior quarter.
• Across five years, Revenue topped out at $5.2 million in Q1 2026 and bottomed at $2.2 million in Q1 2022.
• The 5-year median for Revenue is $3.5 million (2023), against an average of $3.7 million.
• Across the five-year window, Revenue dropped 21.09% in 2022 and jumped 71.24% in 2023, its largest moves.
• Year by year, Revenue stood at $2.6 million in 2022, then advanced by 27.21% to $3.3 million in 2023, then climbed by 18.93% to $3.9 million in 2024, then advanced by 22.2% to $4.7 million in 2025, then climbed by 10.21% to $5.2 million in 2026.
• Per Business Quant, the three latest NEPH Revenue figures stand at $5.2 million (Q1 2026), $4.7 million (Q4 2025), and $4.8 million (Q3 2025).